Skip to main navigation Skip to search Skip to main content

A Response to the Letter to the Editor: Osimertinib Leads the Way Towards Improving Outcomes of EGFR-Mutant NSCLC With Leptomeningeal Metastases

  • Jiyun Lee
  • , Myung Ju Ahn
  • Sungkyunkwan University

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e14
JournalJournal of Thoracic Oncology
Volume16
Issue number2
DOIs
StatePublished - Feb 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this